{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:58Z","timestamp":1792784338862,"version":"4.5.0"},"reference-count":361,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NEI\/NIH","award":["R01 EY024349"],"award-info":[{"award-number":["R01 EY024349"]}]},{"name":"NEI\/NIH","award":["P30 EY001792"],"award-info":[{"award-number":["P30 EY001792"]}]},{"name":"US Department of Defense, U.S. ARMY, Vision for Tomorrow (ARD)","award":["MR130543"],"award-info":[{"award-number":["MR130543"]}]}],"content-domain":{"domain":["theocularsurfacejournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jtos.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:05:16Z","timestamp":1529539516000},"page":"398-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["Current and emerging therapies for corneal neovascularization"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-6406","authenticated-orcid":false,"given":"Danial","family":"Roshandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3647-0250","authenticated-orcid":false,"given":"Medi","family":"Eslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Baradaran-Rafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5546-6017","authenticated-orcid":false,"given":"Albert Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaliq","family":"Kurji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayena","family":"Jabbehdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Maiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/IIO.0b013e31829ceefa","article-title":"Corneal alkali burns: a review of the literature and proposed protocol for evaluation and treatment","volume":"53","author":"Hamill","year":"2013","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jtos.2018.06.004_bib3","series-title":"Limbal stem cell deficiency and corneal neovascularization. Seminars in ophthalmology","author":"Lim","year":"2009"},{"key":"10.1016\/j.jtos.2018.06.004_bib4","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2018.06.004_bib5","volume":"vol. 37","author":"Colby","year":"1996"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjophthalmol-2011-300856","article-title":"Evaluation of corneal neovascularisation","volume":"95","author":"Faraj","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"J Clin Invest"},{"issue":"6626","key":"10.1016\/j.jtos.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1167\/iovs.05-0309","article-title":"Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis","volume":"46","author":"Ozerdem","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.survophthal.2014.06.001","article-title":"Corneal lymphangiogenesis in herpetic stromal keratitis","volume":"60","author":"Park","year":"2015","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib12","first-page":"768","article-title":"Molecular underpinnings of corneal angiogenesis: advances over the past decade","volume":"9","author":"Abdelfattah","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archopht.1949.00900040416002","article-title":"Vascularization of the cornea; ats experimental induction by small lesions and a new theory of its pathogenesis","volume":"41","author":"Cogan","year":"1949","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0014-4835(66)80004-0","article-title":"The stimulus to neovascularization in the cornea","volume":"5","author":"Maurice","year":"1966","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archopht.1963.00960050244017","article-title":"Experimental corneal vascularization","volume":"70","author":"Levene","year":"1963","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9394(14)72167-1","article-title":"Ocular surface abnormalities in aniridia","volume":"120","author":"Nishida","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ICO.0b013e31818cd299","article-title":"In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"28","author":"Vera","year":"2009","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/15569527.2012.731666","article-title":"Development of a mouse model for sulfur mustard-induced ocular injury and long-term clinical analysis of injury progression","volume":"32","author":"Ruff","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00143661","article-title":"Growth pressure and metaplasia of conjunctival and corneal epithelium","volume":"5\u20136","author":"Friedenwald","year":"1951","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib20","article-title":"Hemilimbal deficiency model of corneal neovascularization: possible invalidity of the limbal barrier concept","volume":"23","author":"Tobaigy","year":"2009","journal-title":"Saudi J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib21","first-page":"1963","article-title":"Proliferation of vascular endothelial cells stimulated in vitro by corneal epithelium","volume":"28","author":"Eliason","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-0420.1997.tb00623.x","article-title":"Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance","volume":"75","author":"Van Setten","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib23","first-page":"1822","article-title":"Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells","volume":"40","author":"Ma","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamaophthalmol.2013.2308","article-title":"Cultivated limbal epithelial transplantation in children with ocular surface burns","volume":"131","author":"Sejpal","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib25","first-page":"961","article-title":"In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells","volume":"139","author":"Adamis","year":"1991","journal-title":"Am J Pathol"},{"issue":"7114","key":"10.1016\/j.jtos.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bjo.2006.107417","article-title":"Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier","volume":"91","author":"Ambati","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"6863","key":"10.1016\/j.jtos.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","article-title":"Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression","volume":"414","author":"Makino","year":"2001","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.jtos.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1076\/ceyr.17.3.238.5222","article-title":"Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas","volume":"17","author":"Kenney","year":"1998","journal-title":"Curr Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib31","first-page":"2517","article-title":"Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment","volume":"42","author":"Lin","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1999.1903","article-title":"Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia","volume":"267","author":"Sheibani","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"10.1016\/j.jtos.2018.06.004_bib33","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1167\/iovs.15-18526","article-title":"Identification of novel endogenous anti(lymph)angiogenic factors in the aqueous humor","volume":"57","author":"Bock","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","article-title":"Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases","volume":"34","author":"Bock","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.preteyeres.2006.09.001","article-title":"Regulation of corneal angiogenesis in limbal stem cell deficiency","volume":"25","author":"Ma","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/lrb.2015.0004","article-title":"The naive murine cornea as a model system to identify novel endogenous regulators of lymphangiogenesis: TRAIL and rtPA","volume":"13","author":"Regenfuss","year":"2015","journal-title":"Lymphatic Res Biol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00003226-200304000-00021","article-title":"Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology","volume":"22","author":"Cursiefen","year":"2003","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1167\/iovs.08-2212","article-title":"Regulation of blood vessel versus lymphatic vessel growth in the cornea","volume":"50","author":"Chung","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib41","first-page":"2127","article-title":"Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin","volume":"43","author":"Cursiefen","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1038\/s41598-017-07806-4","article-title":"Transient ingrowth of lymphatic vessels into the physiologically avascular cornea regulates corneal edema and transparency","volume":"7","author":"Hos","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08820530500509358","article-title":"Angiogenesis and lymphangiogenesis-implications for corneal immunity","volume":"21","author":"Dana","year":"2006","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","article-title":"Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity","volume":"10","author":"Chen","year":"2004","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/ACI.0b013e328357b4a2","article-title":"Corneal angiogenesis and lymphangiogenesis","volume":"12","author":"Regenfuss","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08820530902801320","article-title":"Corneal lymphangiogenesis: implications in immunity","volume":"24","author":"Patel","year":"2009","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":"Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation","volume":"184","author":"Dietrich","year":"2010","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/02713683.2010.502294","article-title":"Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors","volume":"35","author":"Shi","year":"2010","journal-title":"Curr Eye Res"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"issue":"32","key":"10.1016\/j.jtos.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9394(14)73639-6","article-title":"Clinical findings in Brown-McLean syndrome","volume":"115","author":"Gothard","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib53","first-page":"1625","article-title":"A model of angiogenesis in the mouse cornea","volume":"37","author":"Kenyon","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib54","first-page":"182","article-title":"Clinical correlates of common corneal neovascular diseases: a literature review","volume":"8","author":"Abdelfattah","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib55","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis","volume":"55","author":"Sunderkotter","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization","volume":"70","author":"Kvanta","year":"2000","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib58","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1096\/fasebj.6.8.1592209","article-title":"Cytokine regulation of endothelial cell function","volume":"6","author":"Mantovani","year":"1992","journal-title":"Faseb J"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1447-0756.2006.00347.x","article-title":"Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro","volume":"32","author":"Hayashi","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib60","first-page":"797","article-title":"Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1\u00df (IL-1\u00df) in the lens and mice undergoing retinal degeneration","volume":"18","author":"Vinores","year":"2003","journal-title":"Histol Histopathol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","article-title":"Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection","volume":"82","author":"Biswas","year":"2006","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib62","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","article-title":"Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis","volume":"17","author":"Yoshida","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1523-1755.2004.00780.x","article-title":"TGF-\u03b2 induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathways1","volume":"66","author":"Nakagawa","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib64","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2\u2013expressing macrophages is a prerequisite for IL-1\u03b2\u2013induced neovascularization and tumor growth","volume":"115","author":"Nakao","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib65","first-page":"1279","article-title":"Interleukin-8. A corneal factor that induces neovascularization","volume":"141","author":"Strieter","year":"1992","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1076\/ceyr.16.7.670.5057","article-title":"Cytokine expression in the alkali-burned cornea","volume":"16","author":"Sotozono","year":"1997","journal-title":"Curr Eye Res"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib67","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.02-0134fje","article-title":"Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion","volume":"16","author":"Salven","year":"2002","journal-title":"Faseb J"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.exer.2004.08.027","article-title":"The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells","volume":"80","author":"Narayanan","year":"2005","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib69","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.4049\/jimmunol.1102602","article-title":"IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection","volume":"188","author":"Suryawanshi","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib70","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1167\/iovs.05-1491","article-title":"Basement membrane dissolution and reassembly by limbal corneal epithelial cells expanded on amniotic membrane","volume":"47","author":"Li","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib71","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-5793(00)02249-3","article-title":"Generation and degradation of human endostatin proteins by various proteinases","volume":"486","author":"Ferreras","year":"2000","journal-title":"FEBS Lett"},{"issue":"24","key":"10.1016\/j.jtos.2018.06.004_bib73","first-page":"6052","article-title":"The generation of endostatin is mediated by elastase","volume":"59","author":"Wen","year":"1999","journal-title":"Canc Res"},{"issue":"46","key":"10.1016\/j.jtos.2018.06.004_bib74","doi-asserted-by":"crossref","first-page":"28823","DOI":"10.1074\/jbc.272.46.28823","article-title":"Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B\/type IV collagenase (MMP-9)","volume":"272","author":"Patterson","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5966\/sctm.2011-0037","article-title":"Concise review: limbal stem cell deficiency, dysfunction, and distress","volume":"1","author":"Ahmad","year":"2012","journal-title":"Stem Cells Transl Med"},{"issue":"8 Suppl","key":"10.1016\/j.jtos.2018.06.004_bib76","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.ico.0000178736.35297.9d","article-title":"Cellular events in the normal and inflamed cornea","volume":"24","author":"Sonoda","year":"2005","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib77","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0042-6822(03)00112-0","article-title":"Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells","volume":"309","author":"Abraham","year":"2003","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib79","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1167\/iovs.04-1172","article-title":"Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo","volume":"46","author":"Singh","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ceyr.23.1.1.5422","article-title":"Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear","volume":"23","author":"Mastyugin","year":"2001","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","article-title":"Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1","volume":"105","author":"Manalo","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib83","first-page":"511","article-title":"Immunohistochemical detection of bFGF and TNF-alpha in the course of inflammatory angiogenesis in the mouse cornea","volume":"137","author":"Sunderkotter","year":"1990","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib84","first-page":"1112","article-title":"Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea","volume":"40","author":"Edelman","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ico.0000167877.11687.7e","article-title":"Assessment of stromal keratocytes and tear film inflammatory mediators during extended wear of contact lenses","volume":"25","author":"Kallinikos","year":"2006","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib86","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtos.2018.06.004_bib87","first-page":"2773","article-title":"Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization","volume":"40","author":"Sennlaub","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib88","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3565(24)37879-6","article-title":"Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium","volume":"287","author":"Vafeas","year":"1998","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib89","first-page":"2170","article-title":"The effect of hypoxia on endogenous corneal epithelial eicosanoids","volume":"41","author":"Mieyal","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib90","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1167\/iovs.11-8379","article-title":"Nerves and neovessels inhibit each other in the cornea","volume":"54","author":"Ferrari","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J Biochem"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib92","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02713683.2013.850098","article-title":"Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal stem cell deficiency in rabbits","volume":"39","author":"Kadar","year":"2014","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib93","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1398-9995.2008.01858.x","article-title":"Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients","volume":"64","author":"Leonardi","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfb.2007.06.013","article-title":"The expression patterns of vascular endothelial growth factor and thrombospondin 2 after corneal alkali burn","volume":"60","author":"Yan","year":"2007","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.jtos.2018.06.004_bib95","first-page":"864","article-title":"Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1alpha in a mouse model of closed eye contact lens wear","volume":"18","author":"Chen","year":"2012","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib96","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1167\/iovs.04-1203","article-title":"Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema","volume":"46","author":"Shoshani","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"10.1016\/j.jtos.2018.06.004_bib97","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","article-title":"Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis","volume":"75","author":"Zheng","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib98","first-page":"213","article-title":"Flt-1 but not KDR\/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor","volume":"7","author":"Sawano","year":"1996","journal-title":"Cell Growth Differ"},{"issue":"43","key":"10.1016\/j.jtos.2018.06.004_bib99","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.jtos.2018.06.004_bib100","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"10.1016\/j.jtos.2018.06.004_bib101","first-page":"4123","article-title":"VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma","volume":"62","author":"Bates","year":"2002","journal-title":"Canc Res"},{"issue":"13","key":"10.1016\/j.jtos.2018.06.004_bib102","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.onc.1202527","article-title":"VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells","volume":"18","author":"Takahashi","year":"1999","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.jtos.2018.06.004_bib103","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice","volume":"95","author":"Hiratsuka","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib104","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1074\/jbc.M110.165605","article-title":"RACK1 regulates VEGF\/Flt1-mediated cell migration via activation of a PI3K\/Akt pathway","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.jtos.2018.06.004_bib105","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1038\/onc.2015.516","article-title":"A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/ATVBAHA.111.240622","article-title":"Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis","volume":"32","author":"Le Jan","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(86)90733-6","article-title":"The biology of platelet-derived growth factor","volume":"46","author":"Ross","year":"1986","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib108","first-page":"1364","article-title":"Effect of PDGF, IL-1alpha, and BMP2\/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea","volume":"40","author":"Kim","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib109","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2004.03.003","article-title":"PDGF signaling in cells and mice","volume":"15","author":"Tallquist","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib110","first-page":"637","article-title":"Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells","volume":"34","author":"Hoppenreijs","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cytogfr.2004.03.005","article-title":"Insight into the physiological functions of PDGF through genetic studies in mice","volume":"15","author":"Betsholtz","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"14","key":"10.1016\/j.jtos.2018.06.004_bib112","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","article-title":"Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse","volume":"126","author":"Hellstrom","year":"1999","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib113","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1096\/fj.00-0693fje","article-title":"Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival","volume":"15","author":"Reinmuth","year":"2001","journal-title":"Faseb J"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib114","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1167\/iovs.05-1071","article-title":"The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization","volume":"47","author":"Dell","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00417-011-1709-6","article-title":"Combination of vascular endothelial growth factor receptor\/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization","volume":"249","author":"Chaoran","year":"2011","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib116","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0420.2005.00439.x","article-title":"Expression of basic fibroblast growth factor in rabbit corneal alkali wounds in the presence and absence of granulocytes","volume":"83","author":"Gan","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib117","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib118","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"Pt 2","key":"10.1016\/j.jtos.2018.06.004_bib119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib120","first-page":"1835","article-title":"Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro","volume":"150","author":"Papapetropoulos","year":"1997","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0701436","article-title":"Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2","volume":"122","author":"Sakkoula","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtos.2018.06.004_bib122","first-page":"715","article-title":"Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review)","volume":"2","author":"Vincenzochiarugi LMA","year":"1998","journal-title":"Int J Mol Med"},{"issue":"1\u20133","key":"10.1016\/j.jtos.2018.06.004_bib123","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2004.07.030","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"500","author":"Kleinert","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib124","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jnci\/90.8.587","article-title":"Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer","volume":"90","author":"Gallo","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.jtos.2018.06.004_bib125","first-page":"6402","article-title":"Loss of nitric oxide synthase type ii inhibits ocular neovascularization in mice; corneal neovascularization and argon laser-induced choroidal neovascularization","volume":"52","author":"Fujita","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib126","first-page":"2773","article-title":"Nitric oxide synthase\u2013ii is expressed in severe corneal alkali burns and inhibits neovascularization","volume":"40","author":"Sennlaub","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib127","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","article-title":"Nitric oxide synthase modulates angiogenesis in response to tissue ischemia","volume":"101","author":"Murohara","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib128","doi-asserted-by":"crossref","first-page":"H1054","DOI":"10.1152\/ajpheart.1998.274.3.H1054","article-title":"VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells","volume":"274","author":"Hood","year":"1998","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1006\/bbrc.1993.1543","article-title":"Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules","volume":"192","author":"Ziche","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"32","key":"10.1016\/j.jtos.2018.06.004_bib130","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1073\/pnas.0602544103","article-title":"Nitric oxide activation of guanylyl cyclase in cells revisited","volume":"103","author":"Roy","year":"2006","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"24","key":"10.1016\/j.jtos.2018.06.004_bib131","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1158\/0008-5472.CAN-04-2052","article-title":"Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis","volume":"64","author":"Croft","year":"2004","journal-title":"Canc Res"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib132","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/excr.1999.4481","article-title":"Subcellular localization of RhoA and ezrin at membrane ruffles of human endothelial cells: differential role of collagen and fibronectin","volume":"249","author":"Menager","year":"1999","journal-title":"Exp Cell Res"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib133","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1210\/me.2005-0259","article-title":"Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA\/Rho kinase\/moesin pathway","volume":"20","author":"Simoncini","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib134","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/89083","article-title":"The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors","volume":"7","author":"Pola","year":"2001","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/nm1313","article-title":"Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling","volume":"11","author":"Kusano","year":"2005","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib136","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1096\/fj.09-145102","article-title":"RhoA\/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis","volume":"24","author":"Bryan","year":"2010","journal-title":"Faseb J"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib137","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.yjmcc.2010.05.003","article-title":"Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells","volume":"49","author":"Renault","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib138","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1091\/mbc.e05-12-1158","article-title":"Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor","volume":"17","author":"Le Boeuf","year":"2006","journal-title":"Mol Biol Cell"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib139","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.RES.0000174287.17953.83","article-title":"Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation","volume":"97","author":"Hyvelin","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10384-007-0487-5","article-title":"Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor","volume":"52","author":"Hata","year":"2008","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib141","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/1535-7163.MCT-06-0689","article-title":"Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo","volume":"6","author":"Yin","year":"2007","journal-title":"Mol Canc Therapeut"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib142","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat Rev Canc"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib143","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.yexcr.2012.12.023","article-title":"Wnt signaling in the vasculature","volume":"319","author":"Reis","year":"2013","journal-title":"Exp Cell Res"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib144","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","article-title":"The role of wnt signaling in physiological and pathological angiogenesis","volume":"107","author":"Dejana","year":"2010","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853890.2010.532150","article-title":"Vascular endothelial growth factors in retinal and choroidal neovascular diseases","volume":"44","author":"Kinnunen","year":"2012","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib146","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.survophthal.2015.11.006","article-title":"Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea","volume":"61","author":"Chang","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib147","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/ATVBAHA.114.304627","article-title":"Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization","volume":"35","author":"Wang","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtos.2018.06.004_bib148","series-title":"Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells","author":"Benko","year":"2008"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","article-title":"A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-\u03baB activation","volume":"27","author":"Hasegawa","year":"2008","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/ICO.0b013e3182781ea4","article-title":"The role of Nod1 signaling in corneal neovascularization","volume":"32","author":"Kim","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2005.09.003","article-title":"Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation","volume":"141","author":"Inatomi","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib152","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bjophthalmol-2015-306686","article-title":"Clinical evaluation and characterisation of corneal vascularisation","volume":"100","author":"Faraj","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib153","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib154","first-page":"517","article-title":"Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic","volume":"76","author":"Ziche","year":"1997","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib156","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/bjophthalmol-2011-300638","article-title":"Validation of a semi-automated computer-aided technique for quantifying corneal vascularisation and scarring","volume":"95","author":"Tatham","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib157","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib158","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib159","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1167\/iovs.11-8014","article-title":"Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography","volume":"53","author":"Anijeet","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib160","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2012.04.021","article-title":"Quantifying changes in corneal neovascularization using fluorescein and indocyanine green angiography","volume":"154","author":"Kirwan","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib161","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2015.05.017","article-title":"Optical coherence tomography angiography for anterior segment vasculature imaging","volume":"122","author":"Ang","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib162","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/bjophthalmol-2015-307338","article-title":"En face optical coherence tomography angiography for corneal neovascularisation","volume":"100","author":"Ang","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib163","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/ICO.0000000000000609","article-title":"Angiographic and in vivo confocal microscopic characterization of human corneal blood and presumed lymphatic neovascularization: a pilot study","volume":"34","author":"Romano","year":"2015","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib164","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1167\/iovs.09-4407","article-title":"Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy","volume":"51","author":"Peebo","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.jtos.2018.06.004_bib165","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1167\/iovs.17-22286","article-title":"Label-free in vivo imaging of corneal lymphatic vessels using microscopic optical coherence tomography","volume":"58","author":"Horstmann","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib166","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00003226-198501000-00008","article-title":"Experimental corneal neovascularization: biomicroscopic, angiographic, and morphologic correlation","volume":"4","author":"Burger","year":"1985","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib167","first-page":"2014","article-title":"Inhibition of corneal neovascularization by topical and subconjunctival tigecycline","author":"Goktas","year":"2014","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib168","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1167\/iovs.14-15638","article-title":"Consensus statement on the immunohistochemical detection of ocular lymphatic vessels","volume":"55","author":"Schroedl","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib169","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00003226-199811000-00008","article-title":"Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization","volume":"17","author":"Cursiefen","year":"1998","journal-title":"Cornea"},{"issue":"4\u20135","key":"10.1016\/j.jtos.2018.06.004_bib170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08820538.2011.588652","article-title":"Inflammatory corneal neovascularization: etiopathogenesis","volume":"26","author":"Clements","year":"2011","journal-title":"Semin Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib171","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1167\/iovs.10-5455","article-title":"Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis","volume":"51","author":"Liclican","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib172","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/jop.1999.15.413","article-title":"Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization","volume":"15","author":"McNatt","year":"1999","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2018.06.004_bib173","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.survophthal.2006.11.003","article-title":"Mechanism of action of the angiostatic cortisene anecortave acetate","volume":"52","author":"Clark","year":"2007","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib174","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib175","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1167\/iovs.07-1527","article-title":"Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs","volume":"49","author":"Pakneshan","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib176","first-page":"205","article-title":"Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs","volume":"99","author":"Flach","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib177","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","article-title":"Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2","volume":"193","author":"Hernandez","year":"2001","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib178","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00417-013-2467-4","article-title":"Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits","volume":"251","author":"Bucak","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib179","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ophtha.2014.03.016","article-title":"High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty","volume":"121","author":"Bock","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib181","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(01)00759-X","article-title":"Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts","volume":"108","author":"Sloper","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib182","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/02713683.2010.516620","article-title":"The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization","volume":"36","author":"Turgut","year":"2011","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib183","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5500\/wjt.v6.i1.183","article-title":"Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation","volume":"6","author":"Baroja-Mazo","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.jtos.2018.06.004_bib184","doi-asserted-by":"crossref","first-page":"40308","DOI":"10.1038\/srep40308","article-title":"Rapamycin prolongs the survival of corneal epithelial cells in culture","volume":"7","author":"Gidfar","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib185","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1167\/iovs.13-11684","article-title":"Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-beta1\/ERK pathways regulation","volume":"54","author":"Shin","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib186","first-page":"97","article-title":"The effects of topical everolimus and sunitinib on corneal neovascularization","volume":"35","author":"Cakmak","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib187","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/02713683.2014.914541","article-title":"Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats","volume":"40","author":"Sari","year":"2015","journal-title":"Curr Eye Res"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib188","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/ICO.0000000000000220","article-title":"Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits","volume":"33","author":"Yoo","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib189","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/ICL.0000000000000071","article-title":"Tumor necrosis factor-alpha inhibitors as a treatment of corneal hemangiogenesis and lymphangiogenesis","volume":"41","author":"Ferrari","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICO.0b013e318271cc2a","article-title":"The effect of topical infliximab on corneal neovascularization in rabbits","volume":"32","author":"Kim","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib191","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1167\/iovs.12-10782","article-title":"Safety and efficacy of topical infliximab in a mouse model of ocular surface ScarringSafety and efficacy of topical infliximab","volume":"54","author":"Ferrari","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib192","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ICO.0000000000000071","article-title":"Alkali burn to the eye: protection using TNF-\u03b1 inhibition","volume":"33","author":"Cade","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib193","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcjo.2012.12.003","article-title":"Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization","volume":"48","author":"Ozdemir","year":"2013","journal-title":"Can J Ophthalmol\/J Can Ophtalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib194","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1542-0124(11)70035-0","article-title":"Anti-vegf treatment of corneal neovascularization","volume":"9","author":"Keating","year":"2011","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib196","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajo.2012.06.007","article-title":"Short-term topical bevacizumab in the treatment of stable corneal neovascularization","volume":"154","author":"Cheng","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib197","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib198","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","article-title":"Corneal penetration of topical and subconjunctival bevacizumab","volume":"52","author":"Dastjerdi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib199","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181e458c5","article-title":"Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition","volume":"30","author":"Chu","year":"2011","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib200","first-page":"588","article-title":"Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization","volume":"6","author":"Kim","year":"2013","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib201","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000337139","article-title":"Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model","volume":"48","author":"Oner","year":"2012","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0b013e3182542613","article-title":"Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis","volume":"32","author":"Papathanassiou","year":"2013","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib203","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","article-title":"Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab","volume":"32","author":"Chu","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib204","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5301\/ejo.5000391","article-title":"The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model","volume":"24","author":"Liarakos","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/15569527.2013.813030","article-title":"Topical and subconjunctival ranibizumab (lucentis) for corneal neovascularization in experimental rat model","volume":"33","author":"Turkcu","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib206","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","article-title":"Topical ranibizumab as a treatment of corneal neovascularization","volume":"32","author":"Ferrari","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib207","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3341\/kjo.2014.28.2.177","article-title":"Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment","volume":"28","author":"Ahn","year":"2014","journal-title":"Kor J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3341\/kjo.2013.27.4.235","article-title":"The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study","volume":"27","author":"Kim","year":"2013","journal-title":"Kor J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib209","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib210","first-page":"136","article-title":"Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model","volume":"6","author":"Akar","year":"2013","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-14-17","article-title":"Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Biotechnol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/112067211002000106","article-title":"VEGF Trap(R1R2) suppresses experimental corneal angiogenesis","volume":"20","author":"Oliveira","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/ICO.0000000000000507","article-title":"Inhibitory effect of topical aflibercept on corneal neovascularization in rabbits","volume":"34","author":"Park","year":"2015","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib214","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/TP.0000000000000512","article-title":"VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation","volume":"99","author":"Dohlman","year":"2015","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib215","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1167\/iovs.05-0105","article-title":"Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis","volume":"46","author":"Berdugo","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib216","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ceo.12085","article-title":"Bevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in rats","volume":"41","author":"Kim","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib217","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00417-014-2851-8","article-title":"Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab","volume":"253","author":"Dekaris","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib218","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib219","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","article-title":"Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial","volume":"97","author":"Petsoglou","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","article-title":"Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis","volume":"33","author":"Dan","year":"2008","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib221","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00417-010-1539-y","article-title":"The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats","volume":"249","author":"Su","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib222","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/02713683.2013.833246","article-title":"The effect of topical doxycycline on corneal neovascularization","volume":"39","author":"Jovanovic","year":"2014","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib223","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1167\/iovs.12-10323","article-title":"Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism","volume":"54","author":"Su","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib224","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1167\/iovs.11-7255","article-title":"Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects","volume":"52","author":"Su","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041858","article-title":"Minocycline inhibits alkali burn-induced corneal neovascularization in mice","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib226","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0204183","volume":"46","author":"Sun","year":"2003","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib227","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1078-0432.CCR-06-2328","article-title":"Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma","volume":"13","author":"Goodman","year":"2007","journal-title":"Clin Canc Res"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib228","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1167\/iovs.12-10856","article-title":"Sunitinib inhibits inflammatory corneal LymphangiogenesisSunitinib inhibits corneal neovascularization","volume":"54","author":"Detry","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib229","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/ICO.0b013e3182801645","article-title":"Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model","volume":"32","author":"Ko","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib231","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/02713683.2013.833629","article-title":"Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cells","volume":"39","author":"Bayyoud","year":"2014","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib232","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1167\/iovs.12-11032","article-title":"Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization","volume":"54","author":"Amparo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"10.1016\/j.jtos.2018.06.004_bib233","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Canc Res"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib234","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ICO.0b013e31823f8b9c","article-title":"Inhibition of corneal neovascularization in rats by systemic administration of sorafenib","volume":"31","author":"Seo","year":"2012","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib235","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(12)70364-9","article-title":"Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial","volume":"13","author":"Eisen","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib236","first-page":"220","article-title":"Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization","volume":"7","author":"Onder","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.06.004_bib237","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fonc.2013.00250","article-title":"Targeted therapy for breast cancer prevention","volume":"3","author":"den Hollander","year":"2013","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib238","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ceo.12500","article-title":"Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization","volume":"43","author":"Kaya","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2018.06.004_bib239","first-page":"688","article-title":"Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice","volume":"21","author":"Zeng","year":"2015","journal-title":"Mol Vis"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib240","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/acs.jmedchem.5b00308","article-title":"Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors","volume":"58","author":"Boland","year":"2015","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib241","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/ICO.0000000000000493","article-title":"Inhibition of rho-associated kinase prevents pathological wound healing and neovascularization after corneal trauma","volume":"34","author":"Sijnave","year":"2015","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib242","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/ICO.0000000000000419","article-title":"Corneal fine needle diathermy with adjuvant bevacizumab to treat corneal neovascularization in children","volume":"34","author":"Elbaz","year":"2015","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib243","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3928\/1081-597X-19941101-08","article-title":"Effects of laser photocoagulation on corneal neovascularization in rabbits","volume":"10","author":"Park","year":"1994","journal-title":"J Refract Corneal Surg"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib244","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199305000-00001","article-title":"Biomicroscopic and histopathologic observations after corneal laser photocoagulation in a rabbit model of corneal neovascularization","volume":"12","author":"Hemady","year":"1993","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3928\/1081-597X-19950101-12","article-title":"Comparison of yellow dye, continuous wave Nd:YAG, and argon green laser on experimentally induced corneal neovascularization","volume":"11","author":"Krasnick","year":"1995","journal-title":"J Refract Surg"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib246","first-page":"291","article-title":"Q-switched Nd:YAG laser treatment for corneal neovascularization","volume":"36","author":"Goto","year":"1992","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib247","first-page":"235","article-title":"Frequency doubled Nd:YAG (532 nm) laser photocoagulation in corneal vascularisation: efficacy and time sequenced changes","volume":"49","author":"Sharma","year":"2001","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib248","article-title":"Role of frequency doubled Nd: yag laser in treatment of corneal neovascularisation","volume":"10","author":"Kumar","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib249","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00003226-199405000-00013","article-title":"Hemorrhage complicating YAG laser feeder vessel coagulation of cornea vascularization","volume":"13","author":"Parsa","year":"1994","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib250","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/bjo.72.12.900","article-title":"Argon laser treatment of lipid keratopathy","volume":"72","author":"Marsh","year":"1988","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib251","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjophthalmol-2014-304891","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"98","author":"Faraj","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib252","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2013-303729","article-title":"Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation","volume":"98","author":"Trikha","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib253","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib254","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0974-9233.95246","article-title":"Photodynamic therapy with verteporfin for corneal neovascularization","volume":"19","author":"Al-Torbak","year":"2012","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib255","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.optm.2010.09.012","article-title":"Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin","volume":"82","author":"Al-Abdullah","year":"2011","journal-title":"Optometry"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib256","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archopht.126.8.1059","article-title":"Temporary sutureless amniotic membrane patch for acute alkaline burns","volume":"126","author":"Kheirkhah","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib257","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00417-014-2633-3","article-title":"Anti-neovascular effect of chondrocyte-derived extracellular matrix on corneal alkaline burns in rabbits","volume":"252","author":"Lee","year":"2014","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib258","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.ico.0000116529.35249.fa","article-title":"The Paton lecture: ocular surface transplantation: 10 years' experience","volume":"23","author":"Holland","year":"2004","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib259","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/ICO.0b013e31828d06d2","article-title":"Long-term results of amniotic membrane transplantation for partial limbal deficiency","volume":"32","author":"Konomi","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib260","series-title":"Advances in eye research volume 1","article-title":"Conjunctival-limbal autograft (CLAU)","author":"Eslani","year":"2011"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib261","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.eye.6700640","article-title":"Limbal autograft and allograft transplantations in patients with corneal burns","volume":"18","author":"Ozdemir","year":"2004","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib262","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/ICO.0000000000001260","article-title":"Long-term ocular surface stability in conjunctival limbal autograft donor eyes","volume":"36","author":"Cheung","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib263","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000315020","article-title":"Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency","volume":"45","author":"Pauklin","year":"2010","journal-title":"Dev Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib264","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajo.2011.09.016","article-title":"Clinical outcomes of repeat autologous cultivated limbal epithelial transplantation for ocular surface burns","volume":"153","author":"Basu","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"3\u20134","key":"10.1016\/j.jtos.2018.06.004_bib265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/08820538.2012.680641","article-title":"Cultivated limbal and oral mucosal epithelial transplantation","volume":"27","author":"Eslani","year":"2012","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib266","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0161-6420(02)00960-0","article-title":"Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency","volume":"109","author":"Solomon","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib267","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(00)00475-9","article-title":"Living related conjunctival limbal allograft for the treatment of stem cell deficiency","volume":"108","author":"Daya","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.06.004_bib268","first-page":"677","article-title":"Epithelial transplantation for the management of severe ocular surface disease","volume":"94","author":"Holland","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib269","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jtos.2016.09.002","article-title":"Current and upcoming therapies for ocular surface chemical injuries","volume":"15","author":"Baradaran-Rafii","year":"2017","journal-title":"Ocul Surf"},{"issue":"9057","key":"10.1016\/j.jtos.2018.06.004_bib270","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","article-title":"Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium","volume":"349","author":"Pellegrini","year":"1997","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib271","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/bjophthalmol-2011-300352","article-title":"Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study","volume":"95","author":"Sangwan","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib272","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bjophthalmol-2011-301164","article-title":"Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency","volume":"96","author":"Sangwan","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib273","first-page":"988","article-title":"Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy","volume":"7","author":"Guarnieri","year":"2014","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib274","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jtos.2017.08.006","article-title":"Midterm outcomes of penetrating keratoplasty after cultivated oral mucosal epithelial transplantation in chemical burn","volume":"15","author":"Baradaran-Rafii","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.06.004_bib275","first-page":"2237","article-title":"Review: mesenchymal stem cells and corneal reconstruction","volume":"19","author":"Yao","year":"2013","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib276","first-page":"1","article-title":"Adult corneal stem cells and alternative sources for regenerative therapy for the cornea","volume":"23","author":"Espandar","year":"2013","journal-title":"CML \u2013 Ophthalmol"},{"issue":"9624","key":"10.1016\/j.jtos.2018.06.004_bib277","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jtos.2018.06.004_bib278","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib279","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030842","article-title":"Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.jtos.2018.06.004_bib280","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1089\/scd.2013.0568","article-title":"Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-gamma-treated mesenchymal stromal cells","volume":"23","author":"Javorkova","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jtos.2018.06.004_bib281","first-page":"1304","article-title":"Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats","volume":"16","author":"Jiang","year":"2010","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib282","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.kjms.2012.08.002","article-title":"Effects of cultured human adipose-derived stem cells transplantation on rabbit cornea regeneration after alkaline chemical burn","volume":"29","author":"Lin","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib283","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.exer.2013.10.002","article-title":"Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface","volume":"116","author":"Cejkova","year":"2013","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib284","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcyt.2013.07.006","article-title":"Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas","volume":"16","author":"Bray","year":"2014","journal-title":"Cytotherapy"},{"issue":"39","key":"10.1016\/j.jtos.2018.06.004_bib285","doi-asserted-by":"crossref","first-page":"16875","DOI":"10.1073\/pnas.1012451107","article-title":"Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury","volume":"107","author":"Oh","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib286","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1167\/iovs.17-22680","article-title":"Corneal mesenchymal stromal cells are directly antiangiogenic via PEDF and sFLT-1","volume":"58","author":"Eslani","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib287","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/stem.2781","article-title":"Cornea-derived mesenchymal stromal cells therapeutically modulate macrophage immunophenotype and angiogenic function","volume":"36","author":"Eslani","year":"2018","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib288","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjo.2011.204701","article-title":"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable","volume":"96","author":"Cursiefen","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib289","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IIO.0000000000000200","article-title":"Novel treatments for corneal angiogenesis","volume":"57","author":"Syed","year":"2017","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib290","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib291","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.survophthal.2017.10.006","article-title":"Gene-based antiangiogenic applications for corneal neovascularization","volume":"63","author":"Liu","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib292","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11373-007-9153-7","article-title":"Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model","volume":"14","author":"Lai","year":"2007","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib293","first-page":"2344","article-title":"Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis","volume":"13","author":"Cheng","year":"2007","journal-title":"Mol Vis"},{"issue":"2\u20133","key":"10.1016\/j.jtos.2018.06.004_bib294","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainresbull.2009.07.005","article-title":"Transduction efficiency of AAV 2\/6, 2\/8 and 2\/9 vectors for delivering genes in human corneal fibroblasts","volume":"81","author":"Sharma","year":"2010","journal-title":"Brain Res Bull"},{"issue":"12","key":"10.1016\/j.jtos.2018.06.004_bib295","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/ICO.0b013e318206c893","article-title":"Gene transfer using micellar nanovectors inhibits corneal neovascularization in vivo","volume":"30","author":"Iriyama","year":"2011","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib296","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1167\/iovs.11-9139","article-title":"Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization","volume":"53","author":"Qazi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib297","first-page":"286","article-title":"Inhibitory effects of S100A4 gene silencing on alkali burn-induced corneal neovascularization: an in vivo study","volume":"23","author":"Wang","year":"2017","journal-title":"Mol Vis"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib298","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/02713681003597230","article-title":"A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization","volume":"35","author":"Zuo","year":"2010","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib299","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21655979.2017.1299834","article-title":"CRISPR-Cas9: from a bacterial immune system to genome-edited human cells in clinical trials","volume":"8","author":"Kick","year":"2017","journal-title":"Bioengineered"},{"issue":"Suppl 7","key":"10.1016\/j.jtos.2018.06.004_bib300","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.5301\/ejo.5000050","article-title":"Triple therapy for corneal neovascularization: a case report","volume":"22","author":"Veritti","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib301","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2010.05.002","article-title":"Regression of aggressive corneal vascularization after photodynamic therapy, subconjunctival Avastin injections and topical cyclosporin-A 1% drops: a case report","volume":"24","author":"Kirat","year":"2010","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.06.004_bib302","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis (Lond)"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib303","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/cbdd.13018","article-title":"Recent drug therapies for corneal neovascularization","volume":"90","author":"Liu","year":"2017","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib304","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ICO.0b013e3181dc81a0","article-title":"Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization","volume":"30","author":"You","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib305","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-017-0786-x","article-title":"Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome","author":"Yoon","year":"2017","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib306","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.3390\/ijms14048291","article-title":"Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model","volume":"14","author":"Kuo","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2018.06.004_bib307","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.colsurfb.2017.07.057","article-title":"Combination of dexamethasone and Avastin((R)) by supramolecular hydrogel attenuates the inflammatory corneal neovascularization in rat alkali burn model","volume":"159","author":"Huang","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.jtos.2018.06.004_bib308","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14874","article-title":"UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival","author":"Hou","year":"2018","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib309","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jmf.2014.3404","article-title":"Diospyros kaki extract inhibits alkali burn-induced corneal neovascularization","volume":"19","author":"Yang","year":"2016","journal-title":"J Med Food"},{"issue":"7","key":"10.1016\/j.jtos.2018.06.004_bib310","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-015-2954-x","article-title":"Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model","volume":"253","author":"Kuerten","year":"2015","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib311","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/ICO.0b013e3181cc7987","article-title":"Inhibition of chemical cautery\u2013induced corneal neovascularization by topical pigment epithelium\u2013derived factor eyedrops","volume":"29","author":"Jin","year":"2010","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib312","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/ICO.0000000000000343","article-title":"Topically administered gold nanoparticles inhibit experimental corneal neovascularization in mice","volume":"34","author":"Cho","year":"2015","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2018.06.004_bib313","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/02713683.2014.968934","article-title":"Critical role of IP-10 on reducing experimental corneal neovascularization","volume":"40","author":"Liu","year":"2015","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib314","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1167\/iovs.11-8722","article-title":"Netrin-1 simultaneously suppresses corneal inflammation and neovascularization","volume":"53","author":"Han","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122951","article-title":"Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.jtos.2018.06.004_bib316","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1111\/bph.13177","article-title":"Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization","volume":"172","author":"Kim","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib317","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/ICO.0000000000000104","article-title":"Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits","volume":"33","author":"Koh","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib318","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejphar.2014.06.019","article-title":"Largazole, an inhibitor of class I histone deacetylases, attenuates inflammatory corneal neovascularization","volume":"740","author":"Zhou","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib319","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1167\/iovs.14-14023","article-title":"Serine proteinase inhibitor SERPINA3K suppresses corneal neovascularization via inhibiting wnt signaling and VEGFSERPINA3K and corneal neovascularization","volume":"55","author":"Zhou","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000358201","article-title":"The effect of TC14012 on alkali burn-induced corneal neovascularization in mice","volume":"52","author":"Shen","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib321","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000366283","article-title":"Antiangiogenic effect of itraconazole on corneal neovascularization: a pilot experimental investigation","volume":"52","author":"Goktas","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib322","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1167\/iovs.14-14553","article-title":"NK1 receptor antagonists as a new treatment for corneal NeovascularizationInhibition of substance P (NK1) receptor in cornea","volume":"55","author":"Bignami","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib323","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/ICO.0b013e3182a48009","article-title":"Subconjunctival injection of low-molecular-weight heparin\u2013taurocholate 7 inhibits corneal neovascularization","volume":"32","author":"Yoon","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib324","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2013.03.014","article-title":"A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo","volume":"112","author":"Ge","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2018.06.004_bib325","first-page":"1163","article-title":"Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats","volume":"7","author":"Li","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2018.06.004_bib326","series-title":"ADP-ribosylation factor as a novel target for corneal neovascularization regression","author":"Dai","year":"2012"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib327","first-page":"251","article-title":"Inhibitory effect of CCR3 signal on alkali-induced corneal neovascularization","volume":"5","author":"Zhou","year":"2012","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib328","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ICO.0b013e318241433b","article-title":"Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model","volume":"31","author":"Lee","year":"2012","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib329","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-012-2008-6","article-title":"The subconjunctival use of cetuximab and bevacizumab in inhibition of corneal angiogenesis","volume":"250","author":"Tunik","year":"2012","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"13","key":"10.1016\/j.jtos.2018.06.004_bib330","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1167\/iovs.12-10064","article-title":"Topical administration of Peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet RadiationPRDX6 inhibited inflammation and neovascularization","volume":"53","author":"Shi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib331","first-page":"7","article-title":"Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1\u03b1 antibody","volume":"5","author":"Liu","year":"2012","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib332","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3181e46ad8","article-title":"The effect of methotrexate on corneal neovascularization in rabbits","volume":"30","author":"Byun","year":"2011","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib333","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1167\/iovs.10-6167","article-title":"Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse cornealalkali-burn model","volume":"52","author":"Kubota","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib334","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-010-1457-z","article-title":"Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization","volume":"67","author":"Lopez","year":"2011","journal-title":"Canc Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib335","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000322804","article-title":"Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization","volume":"46","author":"Wang","year":"2011","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib336","first-page":"44","article-title":"Effects of AMD3100 subconjunctival injection on alkali burn induced corneal neovascularization in mice","volume":"4","author":"Peng","year":"2011","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib337","first-page":"150","article-title":"Topical dihydroartemisinin inhibits suture-induced neovascularization in rat corneas through ERK1\/2 and p38 pathways","volume":"4","author":"Zhong","year":"2011","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2018.06.004_bib338","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1167\/iovs.10-5576","article-title":"Parstatin suppresses ocular neovascularization and inflammation","volume":"51","author":"Huang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.06.004_bib339","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1167\/iovs.07-1314","article-title":"Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation","volume":"49","author":"Hos","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib340","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10456-018-9594-9","article-title":"Selective IKK2 inhibitor IMD0354 disrupts NF-kappaB signaling to suppress corneal inflammation and angiogenesis","volume":"21","author":"Lennikov","year":"2018","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.jtos.2018.06.004_bib341","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","article-title":"Topical modulation of interleukin-1 activity in corneal neovascularization","volume":"17","author":"Dana","year":"1998","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib342","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/ICO.0000000000000548","article-title":"Inhibition of pathologic corneal neovascularization by topical application of a novel peptide in vivo","volume":"34","author":"Lu","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib343","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.1","article-title":"Topical use of angiopoietin-like protein 2 RNAi-loaded lipid nanoparticles suppresses corneal neovascularization","volume":"5","author":"Taketani","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib344","first-page":"56","article-title":"Corneal neovascularization suppressed by TIMP2 released from human amniotic membranes","volume":"21","author":"Ma","year":"2005","journal-title":"Yan Ke Xue Bao"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib345","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1139\/cjpp-2014-0117","article-title":"Suberoylanilide hydroxamic acid suppresses inflammation-induced neovascularization","volume":"92","author":"Zhou","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib346","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/ICO.0b013e3181ae91e3","article-title":"The effect of subconjunctival suramin on corneal neovascularization in rabbits","volume":"29","author":"Lee","year":"2010","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.06.004_bib347","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41598-018-24037-3","article-title":"Fine needle-diathermy regresses pathological corneal (Lymph)Angiogenesis and promotes high-risk corneal transplant survival","volume":"8","author":"Le","year":"2018","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.jtos.2018.06.004_bib348","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1167\/iovs.17-22904","article-title":"Photodynamic therapy leads to time-dependent regression of pathologic corneal (lymph) angiogenesis and promotes high-risk corneal allograft survival","volume":"58","author":"Hou","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib349","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"issue":"5\u20136","key":"10.1016\/j.jtos.2018.06.004_bib350","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000356407","article-title":"High-dose topical bevacizumab for corneal neovascularization","volume":"92","author":"Waisbourd","year":"2013","journal-title":"Pharmacology"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib351","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/ICO.0b013e31823f8d71","article-title":"Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study","volume":"31","author":"Benayoun","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.06.004_bib352","doi-asserted-by":"crossref","first-page":"6084270","DOI":"10.1155\/2016\/6084270","article-title":"Intrastromal injection of bevacizumab in the management of corneal neovascularization: about 25 eyes","volume":"2016","author":"Sarah","year":"2016","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib353","first-page":"1256","article-title":"Efficacy of sub-conjunctival and topical bevacizumab in high-risk corneal transplant survival","volume":"63","author":"Bhatti","year":"2013","journal-title":"J Pakistan Med Assoc"},{"issue":"10","key":"10.1016\/j.jtos.2018.06.004_bib354","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/ICO.0b013e31821379aa","article-title":"Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization","volume":"30","author":"Yeung","year":"2011","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib355","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3928\/15428877-20120726-01","article-title":"Effect of combined topical heparin and steroid on corneal neovascularization in children","volume":"43","author":"Michels","year":"2012","journal-title":"Ophthalmic Surg Laser Imag"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib356","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.06.004_bib357","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2015.02.012","article-title":"Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization","volume":"122","author":"Spiteri","year":"2015","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.jtos.2018.06.004_bib358","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00003226-200211000-00007","article-title":"Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularization","volume":"21","author":"Gordon","year":"2002","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib359","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2005.11.003","article-title":"Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether","volume":"141","author":"Sheppard","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.06.004_bib360","first-page":"313","article-title":"[Photodynamic therapy with verteporfirin in corneal neovascularization]","volume":"48","author":"Verdiguel-Sotelo","year":"2010","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"2","key":"10.1016\/j.jtos.2018.06.004_bib361","first-page":"164","article-title":"[Neovascularization corneal regression in patients treated with photodynamic therapy with verteporfin]","volume":"54","author":"Diaz-Davalos","year":"2016","journal-title":"Rev Med Inst Mex Seguro Soc"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418300247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418300247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:09:48Z","timestamp":1751684988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012418300247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":361,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1542012418300247"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2018.06.004","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and emerging therapies for corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}